These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27178204)

  • 1. Galectin-3 and Risk of Heart Failure and Death in Blacks and Whites.
    McEvoy JW; Chen Y; Halushka MK; Christenson E; Ballantyne CM; Blumenthal RS; Christenson RH; Selvin E
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27178204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifetime risk for heart failure among white and black Americans: cardiovascular lifetime risk pooling project.
    Huffman MD; Berry JD; Ning H; Dyer AR; Garside DB; Cai X; Daviglus ML; Lloyd-Jones DM
    J Am Coll Cardiol; 2013 Apr; 61(14):1510-7. PubMed ID: 23500287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT -pro BNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure.
    Whitman IR; Vittinghoff E; DeFilippi CR; Gottdiener JS; Alonso A; Psaty BM; Heckbert SR; Hoogeveen RC; Arking DE; Selvin E; Chen LY; Dewland TA; Marcus GM
    J Am Heart Assoc; 2019 Apr; 8(7):e010868. PubMed ID: 30912456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity, Galectin-3, and Incident Heart Failure: The ARIC Study.
    Florido R; Kwak L; Echouffo-Tcheugui JB; Zhang S; Michos ED; Nambi V; Goldberg RB; Hoogeveen RC; Lazo M; Gerstenblith G; Post WS; Blumenthal RS; Coresh J; Folsom AR; Selvin E; Ballantyne C; Ndumele CE
    J Am Heart Assoc; 2022 May; 11(9):e023238. PubMed ID: 35491999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of galectin-3 for predicting cause-specific death in hospitalized patients with heart failure.
    Zhang Y; Zhang R; An T; Huang Y; Guo X; Yin S; Wang Y; Ji S; Lv R; Zhang J; Maisel A
    J Card Fail; 2015 Jan; 21(1):51-9. PubMed ID: 25463412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the Meta-Analysis Global Group in Chronic Heart Failure Score in Black Patients Compared With Whites.
    Radjef R; Peterson EL; Michaels A; Liu B; Gui H; Sabbah HN; Spertus JA; Williams LK; Lanfear DE
    Circ Cardiovasc Qual Outcomes; 2019 Jul; 12(7):e004714. PubMed ID: 31266369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT.
    Anand IS; Rector TS; Kuskowski M; Adourian A; Muntendam P; Cohn JN
    Eur J Heart Fail; 2013 May; 15(5):511-8. PubMed ID: 23291728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3 and risk of ischaemic stroke: Reasons for Geographic and Racial Differences in Stroke cohort.
    Arora P; Agarwal Z; Venkatraman A; Callas P; Kissela BM; Jenny NS; Judd SE; Zakai NA; Cushman M
    Eur J Neurol; 2017 Dec; 24(12):1464-1470. PubMed ID: 28872212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels and Change in Galectin-3 and Association With Cardiovascular Events: The ARIC Study.
    Aguilar D; Sun C; Hoogeveen RC; Nambi V; Selvin E; Matsushita K; Saeed A; McEvoy JW; Shah AM; Solomon SD; Boerwinkle E; Ballantyne CM
    J Am Heart Assoc; 2020 Jul; 9(13):e015405. PubMed ID: 32573308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Serial Galectin-3 Measurements in Patients With Acute Heart Failure.
    van Vark LC; Lesman-Leegte I; Baart SJ; Postmus D; Pinto YM; de Boer RA; Asselbergs FW; Wajon EMCJ; Orsel JG; Boersma E; Hillege HL; Akkerhuis KM;
    J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Race and renal impairment in heart failure: mortality in blacks versus whites.
    Smith GL; Shlipak MG; Havranek EP; Masoudi FA; McClellan WM; Foody JM; Rathore SS; Krumholz HM
    Circulation; 2005 Mar; 111(10):1270-7. PubMed ID: 15769768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study.
    Dadu RT; Dodge R; Nambi V; Virani SS; Hoogeveen RC; Smith NL; Chen F; Pankow JS; Guild C; Tang WH; Boerwinkle E; Hazen SL; Ballantyne CM
    Circ Heart Fail; 2013 Sep; 6(5):936-43. PubMed ID: 23861484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative analysis of risk factors for stroke in blacks and whites: the Atherosclerosis Risk in Communities study.
    Huxley RR; Bell EJ; Lutsey PL; Bushnell C; Shahar E; Rosamond W; Gottesman R; Folsom A
    Ethn Health; 2014; 19(6):601-16. PubMed ID: 24261746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Race, gender, and mortality in adults > or =65 years of age with incident heart failure (from the Cardiovascular Health Study).
    Parashar S; Katz R; Smith NL; Arnold AM; Vaccarino V; Wenger NK; Gottdiener JS
    Am J Cardiol; 2009 Apr; 103(8):1120-7. PubMed ID: 19361600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials.
    Meijers WC; Januzzi JL; deFilippi C; Adourian AS; Shah SJ; van Veldhuisen DJ; de Boer RA
    Am Heart J; 2014 Jun; 167(6):853-60.e4. PubMed ID: 24890535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH.
    van der Velde AR; Gullestad L; Ueland T; Aukrust P; Guo Y; Adourian A; Muntendam P; van Veldhuisen DJ; de Boer RA
    Circ Heart Fail; 2013 Mar; 6(2):219-26. PubMed ID: 23395934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial Differences in Sudden Cardiac Death.
    Zhao D; Post WS; Blasco-Colmenares E; Cheng A; Zhang Y; Deo R; Pastor-Barriuso R; Michos ED; Sotoodehnia N; Guallar E
    Circulation; 2019 Apr; 139(14):1688-1697. PubMed ID: 30712378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy.
    Eberly LA; Day SM; Ashley EA; Jacoby DL; Jefferies JL; Colan SD; Rossano JW; Semsarian C; Pereira AC; Olivotto I; Ingles J; Seidman CE; Channaoui N; Cirino AL; Han L; Ho CY; Lakdawala NK
    JAMA Cardiol; 2020 Jan; 5(1):83-91. PubMed ID: 31799990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of black/white differences in colon cancer survival.
    Mayberry RM; Coates RJ; Hill HA; Click LA; Chen VW; Austin DF; Redmond CK; Fenoglio-Preiser CM; Hunter CP; Haynes MA
    J Natl Cancer Inst; 1995 Nov; 87(22):1686-93. PubMed ID: 7473817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.